Foley Represents Nestle Skin Care and Galderma Against Truinject in Successful Institution of Two Inter Partes Reviews of Patents for Injection Training System
17 November 2020
Foley & Lardner is representing Galderma S.A. and Nestle Skin Health, Inc. in two IPR’s at the PTAB, challenging Truinject Corp.’s patents on automated detection of performance characteristics in an injection training system (U.S. Patent Nos. 10,290,231 and 10,290,232) following a district court complaint filed by Truinject based on the patents. On November 17, 2020, the PTAB granted institution of both IPRs, IPR2020-00935 and -00937 on all challenged claims on the requested grounds. Galderma S.A., formerly a subsidiary of Nestlé, is a global pharmaceutical company specializing in dermatological treatments and skin care products. The Foley team includes George Beck, Stephen B. Maebius, Chase Brill, and Kiri Lee Sharon.
People
Related News
24 October 2024
Press Releases
Foley Publishes a ‘How-To’ Manufacturing Guide on Today’s Pressing Legal Challenges and Those that Lie Ahead
Foley & Lardner LLP today released its 2024 End-to-End Manufacturing Manual, a compilation of essays focused on helping companies navigate the ever-changing future of manufacturing.
23 October 2024
Press Releases
Foley Strengthens Florida Presence with Addition of Two Corporate Partners
Foley & Lardner LLP announced today that it has expanded its Innovative Technology Sector and Transactions Practice Group with the addition of partners Joshua Ehrenfeld and Charles Curley to the firm’s Jacksonville office.
14 October 2024
Press Releases
Foley Releases eBook Exploring Developments and Impacts of Artificial Intelligence Advancements
Foley & Lardner LLP today published its second annual eBook that examines Artificial Intelligence with insights on how to navigate the rapidly evolving landscape of this technology as it transforms industries across all economic sectors.